Figure 1 | Scientific Reports

Figure 1

From: Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan

Figure 1

Changes in the clinical parameters of patients with primary and secondary MN during the 1-year follow up. (a) Age at diagnosis. The levels of proteinuria (b,e,h), serum albumin (c,f,i), and serum creatinine (d,g,j) just before the treatment (b,c,d), at 6 months (e,f,g), and at 12 months (h,i,j) after starting treatment. P primary membranous nephropathy, S secondary membranous nephropathy, sAlb serum albumin, sCr serum creatinine, n.s. not significance.

Back to article page